Literature DB >> 28160100

Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial.

Bernhard Michalowsky1, Steffen Flessa2, Tilly Eichler3, Johannes Hertel3, Adina Dreier4, Ina Zwingmann5, Diana Wucherer3, Henriette Rau3, Jochen René Thyrian5, Wolfgang Hoffmann3,4.   

Abstract

The objectives of this cross-sectional analysis were to determine healthcare resource utilization and cost for community-dwelling patients with dementia (PWD) from a payer's and societal perspective, and to analyze the associations between costs and sociodemographic and clinical variables. Analysis of healthcare costs from a payer's perspective was based on a sample of 425 PWD, analysis of healthcare costs from societal perspective on a subsample of 254 PWD and their informal caregivers. Frequency of healthcare resource utilization was assessed by means of questionnaires. Informal care and productivity losses were assessed by using the Resource Utilization in Dementia questionnaire (RUD). Costs were monetarized using standardized unit costs. To analyze the associations, multiple linear regression models were used. Total annual costs per PWD valued 7016€ from a payer's and 25,877€ from a societal perspective, meaning that societal cost is approximately three and a half times as much as payer's expenditures. Costs valuated 5456 € for medical treatments, 1559 € for formal care, 18,327€ for informal care. Productivity losses valued 1297€ for PWD caregivers. Informal care could vary substantially (-21%; +33%) concerning different valuation methods. Medical care costs decreased significantly with progression of dementia and with age. Costs of care double over the stages of dementia. Formal care costs were significantly higher for PWD living alone and informal care costs significantly lower for PWD with an employed caregiver. For all cost categories, deficits in daily living activities were major cost drivers.

Entities:  

Keywords:  Alzheimer´s disease; Cost of illness; Dementia; Healthcare utilization

Mesh:

Year:  2017        PMID: 28160100     DOI: 10.1007/s10198-017-0869-7

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  35 in total

Review 1.  Economic note: cost of illness studies.

Authors:  S Byford; D J Torgerson; J Raftery
Journal:  BMJ       Date:  2000-05-13

2.  Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument.

Authors:  Anders Wimo; Gunilla Nordberg
Journal:  Arch Gerontol Geriatr       Date:  2006-06-13       Impact factor: 3.250

3.  Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.

Authors:  Julio Lopez-Bastida; Pedro Serrano-Aguilar; Lilisbeth Perestelo-Perez; Juan Oliva-Moreno
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

Review 4.  Cost-of-illness analysis. What room in health economics?

Authors:  Rosanna Tarricone
Journal:  Health Policy       Date:  2005-09-01       Impact factor: 2.980

5.  The Bayer Activities of Daily Living Scale (B-ADL).

Authors:  I Hindmarch; H Lehfeld; P de Jongh; H Erzigkeit
Journal:  Dement Geriatr Cogn Disord       Date:  1998       Impact factor: 2.959

6.  Management of the demented elderly patient in the community.

Authors:  K Bergmann; E M Foster; A W Justice; V Matthews
Journal:  Br J Psychiatry       Date:  1978-05       Impact factor: 9.319

Review 7.  Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs.

Authors:  W Quentin; S G Riedel-Heller; M Luppa; A Rudolph; H-H König
Journal:  Acta Psychiatr Scand       Date:  2009-08-19       Impact factor: 6.392

8.  Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany?

Authors:  Bernhard Michalowsky; Tilly Eichler; Jochen René Thyrian; Johannes Hertel; Diana Wucherer; Wolfgang Hoffmann; Steffen Flessa
Journal:  Int Psychogeriatr       Date:  2015-09-22       Impact factor: 3.878

9.  The sensitivity and specificity of cognitive screening instruments to detect cognitive impairment in older adults with severe psychiatric illness.

Authors:  R Scott Mackin; Liat Ayalon; Leilani Feliciano; Patricia A Areán
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-01-25       Impact factor: 2.680

10.  Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data.

Authors:  Larissa Schwarzkopf; Petra Menn; Reiner Leidl; Elmar Graessel; Rolf Holle
Journal:  BMC Health Serv Res       Date:  2013-01-03       Impact factor: 2.655

View more
  10 in total

1.  [Informal care for dementia according to type of service].

Authors:  C Brettschneider; A Hajek; J Stein; T Luck; S Mamone; B Wiese; E Mösch; D Weeg; A Fuchs; M Pentzek; J Werle; S Weyerer; T Mallon; H van den Bussche; K Heser; M Wagner; M Scherer; W Maier; S G Riedel-Heller; H-H König
Journal:  Nervenarzt       Date:  2018-05       Impact factor: 1.214

2.  Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial.

Authors:  Jochen René Thyrian; Johannes Hertel; Diana Wucherer; Tilly Eichler; Bernhard Michalowsky; Adina Dreier-Wolfgramm; Ina Zwingmann; Ingo Kilimann; Stefan Teipel; Wolfgang Hoffmann
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

3.  Associations Between Low-Value Medication in Dementia and Healthcare Costs.

Authors:  Moritz Platen; Steffen Flessa; Anika Rädke; Diana Wucherer; Jochen René Thyrian; Annelie Scharf; Wiebke Mohr; Franka Mühlichen; Wolfgang Hoffmann; Bernhard Michalowsky
Journal:  Clin Drug Investig       Date:  2022-04-28       Impact factor: 3.580

4.  The Multidimensional Prognostic Index Predicts Mortality in Older Outpatients with Cognitive Decline.

Authors:  Femke C M S Overbeek; Jeannette A Goudzwaard; Judy van Hemmen; Rozemarijn L van Bruchem-Visser; Janne M Papma; Harmke A Polinder-Bos; Francesco U S Mattace-Raso
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

5.  Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials.

Authors:  Bernhard Michalowsky; Wolfgang Hoffmann; Kevin Kennedy; Feng Xie
Journal:  Eur J Health Econ       Date:  2020-02-27

Review 6.  Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Authors:  Youssef H El-Hayek; Ryan E Wiley; Charles P Khoury; Ritesh P Daya; Clive Ballard; Alison R Evans; Michael Karran; José Luis Molinuevo; Matthew Norton; Alireza Atri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Can non-pharmacological interventions reduce hospital admissions in people with dementia? A systematic review.

Authors:  Richard Packer; Yoav Ben Shlomo; Penny Whiting
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

Review 8.  Use of Services by People Living Alone With Cognitive Impairment: A Systematic Review.

Authors:  Amy Rosenwohl-Mack; Leslie Dubbin; Anna Chodos; Sarah Dulaney; Min-Lin Fang; Jennifer Merrilees; Elena Portacolone
Journal:  Innov Aging       Date:  2021-01-18

9.  Prevalence of Low-Value Care and Its Associations with Patient-Centered Outcomes in Dementia.

Authors:  Moritz Platen; Steffen Fleßa; Anika Rädke; Diana Wucherer; Jochen René Thyrian; Wiebke Mohr; Annelie Scharf; Franka Mühlichen; Wolfgang Hoffmann; Bernhard Michalowsky
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Informal and formal care among persons with dementia immediately before nursing home admission.

Authors:  Arnt Egil Ydstebø; Jurate Šaltytė Benth; Sverre Bergh; Geir Selbæk; Corinna Vossius
Journal:  BMC Geriatr       Date:  2020-08-18       Impact factor: 3.921

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.